Wedbush Securities Inc Sarepta Therapeutics, Inc. Transaction History

Wedbush Securities Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Oct 20, 2020	SELL	$127.12 - $172.34 $204,536 - $277,295	-1,609 Closed	0 $0
Q2 2020 Jul 16, 2020	SELL	$93.0 - $171.7 $85,374 - $157,620	-918 Reduced 36.33%	1,609 $258,000
Q1 2020 Apr 17, 2020	SELL	$82.38 - $131.64 $14,993 - $23,958	-182 Reduced 6.72%	2,527 $247,000
Q4 2019 Jan 16, 2020	SELL	$76.53 - $135.58 $3,826 - $6,779	-50 Reduced 1.81%	2,709 $350,000
Q3 2019 Oct 17, 2019	BUY	$72.81 - $156.91 $14,562 - $31,382	200 Added 7.82%	2,759 $208,000
Q2 2019 Aug 01, 2019	BUY	$112.21 - $151.95 $287,145 - $388,840	2,559 New	2,559 $389,000

529

84.2M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.4B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Wedbush Securities Inc, based on Form 13F filings with the SEC.

Stay updated on Wedbush Securities Inc with notifications on news.